LIPID MAPS® Lipidomics Gateway was created in 2003 via an NIH “Glue Grant” to provide access to lipid nomenclature, databases, tools, protocols, standards, tutorials, meetings, publications, and other resources and serving the international lipid research community. In July 2016, the Wellcome Trust approved a proposal to further maintain and develop LIPID MAPS®. The bid, led by Valerie O’Donnell (Cardiff) with Michael Wakelam (Babraham, Cambridge), Shankar Subramaniam and Ed Dennis (UCSD) provides £1.3M for 5 yrs.
This new phase will see that LIPID MAPS® is maintained and importantly, further developed in line with the global demand and development of lipidomics. It has recently moved to the UK, preserving its internationally recognized classification system and curated lipid structure database, the largest in the world.
LIPID MAPS® will support the integrative systems-level analyses of multiomics measurements in human physiology and pathophysiology.
The Strategic Management Committee will consider and oversee all matters related to the routine management and maintenance of the LIPID MAPS® website, database and resource. It will adhere to the Wellcome Trust guidelines for management and development of the LIPID MAPS® Lipidomics Gateway.
The Nomenclature Group will continue to monitor and expand the LIPID MAPS® lipid classification, nomenclature, and structural drawing guidelines as appropriate and respond to user input and questions. When warranted it should coordinate publication of updated guidelines.
This group will consider all matters relating to the scientific direction of the LIPID MAPS® Lipidomics Gateway, managed at Cardiff University and operated jointly at Cardiff, Babraham Institute and the University of California San Diego.
This group will work together to identify business development and scientific/academic partnerships. The group will seek to identify engagement opportunities and develop revenue to secure the sustainability of the LIPID MAPS® Lipidomics Gateway.
The Advisory Board initially incorporated all existing members of the International Lipid Classification and Nomenclature Committee (ILCNC), along with new members based on academic background and geographical location. The Advisory Board was replaced the Strategic Management Group, Nomenclature Group, and Lipidomics Tools and Technical Group in September, 2018.